Skip to main content

Branded

  • FDA approves drug, diagnostic test for melanoma

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug and companion diagnostic test for the most dangerous type of skin cancer, the agency said Wednesday.

    The FDA announced the approval of Genentech's and Daiichi Sankyo's Zelboraf (vemurafenib), for patients with late-stage melanoma that can't be removed by surgery. Genentech is the U.S. division of Swiss drug maker Roche.

  • American Diabetes Association, Lilly team for annual Victory Over Diabetes event

    ATLANTA — The American Diabetes Association, with help from drug maker Eli Lilly, once again is hosting a free communitywide event in Atlanta that's designed to educate African-Americans on diabetes management.

  • Savient gout drug shows improvements, according to study

    EAST BRUNSWICK, N.J. — Patients with gout taking a drug made by Savient Pharmaceuticals experienced "significant" improvements, according to results of two late-stage clinical trials published in the Journal of the American Medical Association.

  • Study: Effient reduces cardiovascular risk among younger, heavier patient cohort

    INDIANAPOLIS — A special group of patients who participated in a trial of a heart disease drug made by Daiichi Sankyo and Eli Lilly showed fewer heart attacks, strokes and deaths related to cardiovascular disease than patients taking a competing drug, according to an analysis of study results.

  • Pharmaca debuts vaccine offerings

    BOULDER, Colo. — Pharmaca Integrative Pharmacy on Tuesday announced that it is now offering immunizations for influenza, pneumonia and whooping cough on a walk-in basis. The majority of Pharmaca’s pharmacists are trained to provide the shots to any customer who requests one during open pharmacy hours.

    In addition, Pharmaca will hold Flu Shot Clinics every Tuesday in September, October and November, between 2 p.m. and 6 p.m.

  • Study: Investigational GSK, Impax drug reduces Parkinson's symptoms

    HAYWARD, Calif. — Patients taking an experimental treatment for Parkinson's disease experienced greater reduction in symptoms than those taking a drug already on the market, according to results of a late-stage clinical trial.

  • Viagra patent upheld

    NEW YORK — Pfizer announced that the patent for its popular erectile dysfunction treatment was upheld in court.

    The drug maker said that the U.S. District Court for the Eastern District of Virginia concluded that Pfizer's patent for Viagra was valid and enforceable and prevents generic drug maker Teva from marketing its version of the drug until October 2019. Pfizer noted that litigation on the same patent remains pending against other generic companies, but no trials are scheduled in those other cases.

    The court's decision, however, is subject to appeal by Teva.

  • ECRM announces memorial service celebrating founder Charlie Bowlus

    CLEVELAND — ECRM posted a memorial to founder Charlie Bowlus on its website over the weekend and provided details regarding a celebratory gathering here a week from Monday.

X
This ad will auto-close in 10 seconds